Clinical Pharmacology and Therapeutic Potential of Monoclonal Antibody Treatment in Rheumatoid Arthritis

被引：0
|
作者：
Ernest H. S. Choy
机构：
[1] Guy’s and King’s College Hospitals,Rheumatology Unit
[2] Guy’s Hospital,Rheumatology Unit, 5th Floor, Thomas Guy House
来源：
Drugs & Aging | 1998年 / 12卷
关键词：
Rheumatoid Arthritis; Adis International Limited; Synovial Fluid; Rheumatol; Synovial Joint;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Many monoclonal antibodies (mAb) have been tested in rheumatoid arthritis (RA). Murine antibodies were antigenic and caused human antimouse responses in the recipients. As a result, re-treatments were less effective and were associated with an increased risk of anaphylaxis. Advances in biotechnology have allowed us to develop chimaeric and humanised mAb that are less antigenic than their murine equivalents.
引用
收藏
页码：139 / 148
页数：9
相关论文
共 50 条
  • [31] B cell reductive therapy in the treatment of autoimmune diseases: A focus on monoclonal antibody treatment of rheumatoid arthritis
    Tuscano, JM
    Martin, S
    Song, K
    Wun, T
    HEMATOLOGY, 2005, 10 (06) : 521 - 527
  • [32] Chimeric anti-IL-17 full-length monoclonal antibody is a novel potential candidate for the treatment of rheumatoid arthritis
    Bai, Fuliang
    Tian, Hui
    Niu, Zeshan
    Liu, Mingyao
    Ren, Guiping
    Yu, Yinhang
    Sun, Tian
    Li, Siming
    Li, Deshan
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2014, 33 (03) : 711 - 721
  • [33] Clinical pharmacology and therapeutic potential of artemisinin and its derivatives in the treatment of malaria
    deVries, PJ
    Dien, TK
    DRUGS, 1996, 52 (06) : 818 - 836
  • [34] Clinical pharmacology of combination DMARD therapy in rheumatoid arthritis
    Furst, DE
    JOURNAL OF RHEUMATOLOGY, 1996, 23 : 86 - 90
  • [35] Pharmacogenomics of Monoclonal Antibodies for the Treatment of Rheumatoid Arthritis
    Lim, Sung Ho
    Kim, Khangyoo
    Choi, Chang-Ik
    JOURNAL OF PERSONALIZED MEDICINE, 2022, 12 (08):
  • [36] The clinical pharmacology of therapeutic monoclonal antibodies in the treatment of malignancy; have the magic bullets arrived?
    Newsome, Barrett W.
    Ernstoff, Marc S.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2008, 66 (01) : 6 - 19
  • [37] Network pharmacology analysis and clinical verification of Jishe Qushi capsules in rheumatoid arthritis treatment
    Li, Yujie
    Zhang, Nannan
    Peng, Xin
    Ma, Wukai
    Qin, Yuanxing
    Yao, Xueming
    Huang, Cong
    Zhang, Xudong
    MEDICINE, 2023, 102 (34) : E34883
  • [38] Unveiling the Therapeutic Potential of Berberine in Rheumatoid Arthritis: A Comprehensive Study of Network Pharmacology, Metabolomics, and Intestinal Flora
    Li, Bocun
    Liu, Jing
    He, Chuan
    Deng, Zhou
    Zhou, Xiaohong
    Peng, Rui
    JOURNAL OF INFLAMMATION RESEARCH, 2024, 17 : 10849 - 10869
  • [39] Monoclonal antibody therapy in rheumatoid arthritis - An update on recent progress
    Rankin, ECC
    Isenberg, DA
    CLINICAL IMMUNOTHERAPEUTICS, 1996, 6 (02): : 143 - 153
  • [40] Combining nanotechnology with monoclonal antibody drugs for rheumatoid arthritis treatments
    Chi, Xiao-Kai
    Xu, Xiao-Ling
    Chen, Bang-Yao
    Su, Jin
    Du, Yong-Zhong
    JOURNAL OF NANOBIOTECHNOLOGY, 2023, 21 (01)
12345